QOL Medical, LLC, a ground-breaking, rare disease pharmaceutical company, announced today that the United States (U.S.) Food & Drug Administration (FDA) approved Sucraid® single-use containers…
Summary: Orkambi was first approved in 2015 in the US and is now available in more than 30 countries. Vertex Pharmaceuticals Incorporated…
Synopsis: German drugmaker Boehringer Ingelheim has its first regulatory approval for spesolimab, its antibody therapy for rare and life-threatening skin disorder generalised…
Summary: XenpozymeTM (olipudase alfa-rpcp) approved by FDA as first disease-specific treatment for ASMD (non-CNS manifestations) Xenpozyme is the first approved medication to treat symptoms that are not related…
Highlights: ICAR-Indian Institute of Spices Research, Kozhikode, has signed an agreement with Bayer Crop Science Limited, Thane for capacity building, development of…
In order to gain access to Aerie Pharmaceuticals’ open-angle glaucoma and ocular hypertension medications, Alcon announced that it will acquire the company…
Synopsis : This marks the second indication for Pemazyre, which received accelerated FDA approval in 2020 for adults with previously treated, unresectable…
Summary: Complaints to be filed in both United States and Germany alleging that Pfizer and BioNTech’s COVID-19 vaccine Comirnaty® unlawfully infringes patents…
Summary: The FDA has approved Axsome Therapeutics’ Auvelity for major depressive disorder (MDD) in adults, making it the first and only oral…
NEW ISO INSECTICIDE CANDIDATE PUBLISHED AUGUST 2022 – FLUPYROXYSTROBIN FROM SYNGENTA PARTICIPATIONS AG Flupyroxystrobin compound is covered in European Patent EP242081B1, which…